Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort
Top Cited Papers
- 27 February 2019
- journal article
- research article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 81 (1), 143-151
- https://doi.org/10.1016/j.jaad.2019.02.053
Abstract
No abstract availableKeywords
Funding Information
- Regenron
This publication has 14 references indexed in Scilit:
- Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority TrialThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysisInternational Immunopharmacology, 2017
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trialThe Lancet, 2017
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic DermatitisNew England Journal of Medicine, 2016
- Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trialThe Lancet, 2016
- Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal PolyposisJAMA, 2016
- Dupilumab in Persistent Asthma with Elevated Eosinophil LevelsNew England Journal of Medicine, 2013
- Guidelines of care for atopic dermatitisJournal of the American Academy of Dermatology, 2004
- The eczema area and severity index (EASI): assessment of reliability in atopic dermatitisExperimental Dermatology, 2001
- Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczemaBritish Journal of Dermatology, 1999